Borofalan(10B)
CAS No. 80994-59-8
Borofalan(10B) ( L-4-Boronophenylalanine )
Catalog No. M27860 CAS No. 80994-59-8
Borofalan echibits antineoplastic effects. Borofalan can be used in studies on recurrent or locally advanced head and neck cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 133 | In Stock |
|
10MG | 222 | In Stock |
|
25MG | 439 | In Stock |
|
50MG | 642 | In Stock |
|
100MG | 888 | In Stock |
|
500MG | 1782 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBorofalan(10B)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBorofalan echibits antineoplastic effects. Borofalan can be used in studies on recurrent or locally advanced head and neck cancer.
-
DescriptionBorofalan echibits antineoplastic effects. Borofalan can be used in studies on recurrent or locally advanced head and neck cancer.
-
SynonymsL-4-Boronophenylalanine
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80994-59-8
-
Formula Weight208.2
-
Molecular FormulaC9H12BNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[10B](C1=CC=C(C=C1)C[C@@H](C(=O)O)N)(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chengzheng Wang, Bikash Karmakar, Nasser S. Awwad, Hala A. Ibrahium, Attalla F. El-kott, Mohamed M. Abdel-Daim, Atif Abdulwahab A. Oyouni, Osama Al-Amer, Gaber El-Saber Batiha, Bio-supported of Cu nanoparticles on the surface of Fe3O4 magnetic nanoparticles mediated by Hibiscus sabdariffa extract: Evaluation of its catalytic activity for synthesis of pyrano[3,2-c]chromenes and study of its anti-colon cancer properties, Arabian Journal of Chemistry, Volume 15, Issue 6, 2022, 103809, ISSN 1878-5352.
molnova catalog
related products
-
Isoedultin
Isoedultin is a natural product for research related to life sciences.
-
Misonidazole
Misonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.
-
Ibiglustat
An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access.